Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Submitted by
admin
on April 4, 2017 - 7:35pm
Source:
Endpoints
News Tags:
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
Headline:
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Do Not Allow Advertisers to Use My Personal information
